Literature DB >> 3079257

Wound healing for the clinician.

J Zitelli1.   

Abstract

Wound healing is a complex sequence of events, beginning with tissue injury, mediated by inflammation, and ending long after reepithelialization is complete. Research and controlled clinical experience have provided a better understanding so that clinicians can influence the events of healing to decrease pain, control bleeding, infection, and cosmetic result as well as speed the time for complete healing. The following is a summary of guidelines for the management of wound healing: (1) wound creation; wounds should be created with minimal necrosis of tissue in order to prevent delays in healing. Electrosurgical, cryosurgical, and laser surgical wounds heal more slowly than wounds created by scalpel excision or curettage. Electro-coagulation should be used sparingly in sutured wounds. Large lesions are best treated in a single stage rather than in divided treatments since the rate of wound healing is not proportional to the area but instead to the logarithm of the area. Thus, the total healing time is much shorter if done in a single treatment session. (2) use of drugs; corticosteroids given before or within three days of wounding in dose of prednisone 40 mg or greater will inhibit wound healing. Vitamin A topically or systemically may reverse this inhibition. Aspirin and other nonsteroidal anti-inflammatory agents are more important for their effects on platelet function and bleeding than on wound healing. (3) wound dressings; the use of occlusive dressings to promote moist wound healing is the most significant advance in wound management. Occlusive dressings shorten the time for healing, decrease pain, reduce wound contamination, and improve the cosmetic result. (4) control of wound contraction and scar formation; at the time of wound formation, guiding sutures may be helpful in wound healing by secondary intention in order to control the direction of wound contraction and prevent distortion. Intralesional steroids may be useful for hypertrophic scars and keloids. (5) identification of complications; early identification of certain complications can prevent the delays in healing. These include infection, remembering infrequently cultured organisms such as yeast, malnourishment with protein and mineral deficiency, and the knowledge that adhesive-backed wound dressings can cause rewounding of otherwise normally healing wounds. (6) predicting the cosmetic result; wounds healed by secondary intention may provide a cosmetic result superior to surgical repair. Wounds in concave areas usually heal with a better result than wounds managed by flaps or grafts although wounds on convex surfaces usually look best if a skillful primary closure can be performed without distortion.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1987        PMID: 3079257

Source DB:  PubMed          Journal:  Adv Dermatol        ISSN: 0882-0880


  5 in total

1.  A closer examination of atraumatic dressings for optimal healing.

Authors:  Stephen C Davis; Jie Li; Joel Gil; Jose Valdes; Michael Solis; Ryan Treu; Robert S Kirnser
Journal:  Int Wound J       Date:  2013-09-13       Impact factor: 3.315

Review 2.  Review collagen-based biomaterials for wound healing.

Authors:  Sayani Chattopadhyay; Ronald T Raines
Journal:  Biopolymers       Date:  2014-08       Impact factor: 2.505

Review 3.  Sense and nonsense of scar creams and gels.

Authors:  C J van den Helder; J J Hage
Journal:  Aesthetic Plast Surg       Date:  1994       Impact factor: 2.326

4.  Chitosan malate inhibits growth and exotoxin production of toxic shock syndrome-inducing Staphylococcus aureus strains and group A streptococci.

Authors:  Patrick M Schlievert
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

5.  Zoledronate treatment duration is linked to bisphosphonate-related osteonecrosis of the jaw prevalence in rice rats with generalized periodontitis.

Authors:  Jonathan G Messer; Jessica M Jiron; Jorge L Mendieta Calle; Evelyn J Castillo; Ronnie Israel; Ean G Phillips; Joshua F Yarrow; Catherine Van Poznak; Lakshmyya Kesavalu; Donald B Kimmel; J Ignacio Aguirre
Journal:  Oral Dis       Date:  2019-02-19       Impact factor: 3.511

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.